The shares of Gilead Sciences Inc climbed in early trading Friday after a report that a group of Coronavirus patients being treated with its drug Remdsivir in Chicago, were “seeing rapid recoveries in fever and respiratory symptoms.”
The report, from the medical news publication Stat, cited a
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
